Answers are grounded in this paper and cite their sources.
There are still many controversies in defining and evaluating mastocytosis. One of the aspects that is missing is a system for clinical evaluation of mastocytosis of the skin. A calculation based on a semi-quantitative analysis of three aspects of mastocytosis was designed. The method is called the scoring index of mastocytosis (SCORMA). The clinical use of SCORMA is advocated.
No takes yet. Share an insight, caveat, or question.
Heide et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: